![Value of new spontaneous and carcinogen-induced mouse-derived isograft (MDI) tumor models for drug development of novel immune therapeutic approaches](https://www.reactionbiology.com/wp-content/uploads/2023/07/MDI_Poster_2.png)
![Value of new spontaneous and carcinogen-induced mouse-derived isograft (MDI) tumor models for drug development of novel immune therapeutic approaches](https://www.reactionbiology.com/wp-content/uploads/2023/07/MDI_Poster_2.png)
![Immuno-Oncology Platform – Proprietary Models (MDI)](https://www.reactionbiology.com/wp-content/uploads/2023/07/InfoSheet_MDI.png)
Immuno-Oncology Platform – Proprietary Models (MDI)
![Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019](https://www.reactionbiology.com/wp-content/uploads/2023/07/sMDI_Cancers_including-supplements.png)
Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019
![Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019](https://www.reactionbiology.com/wp-content/uploads/2023/07/cMDI_Cancers_including-supplements.png)
Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019
![In Vivo Pharmacology Brochure](https://www.reactionbiology.com/wp-content/uploads/2023/07/InVivo_Brochure_thumbnail.png)